Arachidonic acid promotes epithelial-to-mesenchymal-like transition in mammary epithelial cells MCF10A

European Journal of Cell Biology

Volumn 89, Issue 6, 2010, Pages 476-488

  Martinez Orozco, Raul ^a   Navarro Tito, Napoleon ^a   Soto Guzman, Adriana ^a   Castro Sanchez, Luis ^a   Perez Salazar, Eduardo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Arachidonic acid; EMT; Mammary cells; MCF10A

Indexed keywords

ARACHIDONIC ACID; BETA CATENIN; CYTOKERATIN 5; CYTOKERATIN 8; FOCAL ADHESION KINASE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NERVE CELL ADHESION MOLECULE; PROTEIN TYROSINE KINASE; UVOMORULIN; VIMENTIN;

ARTICLE; BINDING AFFINITY; BIOACCUMULATION; BREAST EPITHELIUM; CELL JUNCTION; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR PROMOTION;

ARACHIDONIC ACID; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSDIFFERENTIATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MESODERM; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 77951937167     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2009.12.005     Document Type: Article

References (114)

1. Abd El-Rehim D.M., Pinder S.E., Paish C.E., Bell J., Blamey R.W., Robertson J.F., Nicholson R.I., Ellis I.O. Expression of luminal and basal cytokeratins in human breast carcinoma. J. Pathol. 2004, 203:661-671.
2. Agiostratidou G., Hulit J., Phillips G.R., Hazan R.B. Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression. J. Mammary Gland Biol. Neoplasia 2007, 12:127-133.
3. Avizienyte E., Frame M.C. Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr. Opin. Cell Biol. 2005, 17:542-547.
4. Avizienyte E., Wyke A.W., Jones R.J., McLean G.W., Westhoff M.A., Brunton V.G., Frame M.C. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat. Cell Biol. 2002, 4:632-638.
5. Bailey K.M., Liu J. Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase. J. Biol. Chem. 2008, 283:13714-13724.
6. Balsamo J., Arregui C., Leung T., Lilien J. The nonreceptor protein tyrosine phosphatase PTP1B binds to the cytoplasmic domain of N-cadherin and regulates the cadherin-actin linkage. J. Cell Biol. 1998, 143:523-532.
7. Baranwal S., Alahari S.K. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem. Biophys. Res. Commun. 2009, 384:6-11.
8. Bindels S., Mestdagt M., Vandewalle C., Jacobs N., Volders L., Noel A., van Roy F., Berx G., Foidart J.M., Gilles C. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 2006, 25:4975-4985.
9. Bolos V., Peinado H., Perez-Moreno M.A., Fraga M.F., Esteller M., Cano A. The transcription factor slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 2003, 116:499-511.
10. Bowers R.C., Hevko J., Henson P.M., Murphy R.C. A novel glutathione containing eicosanoid (FOG7) chemotactic for human granulocytes. J. Biol. Chem. 2000, 275:29931-29934.
11. Boyer B., Valles A.M., Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol. 2000, 60:1091-1099.
12. Calautti E., Cabodi S., Stein P.L., Hatzfeld M., Kedersha N., Paolo Dotto G. Tyrosine phosphorylation and src family kinases control keratinocyte cell-cell adhesion. J. Cell Biol. 1998, 141:1449-1465.
13. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
14. Chabottaux V., Sounni N.E., Pennington C.J., English W.R., van den Brule F., Blacher S., Gilles C., Munaut C., Maquoi E., Lopez-Otin C., Murphy G., Edwards D.R., Foidart J.M., Noel A. Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Res. 2006, 66:5165-5172.
15. Charvat S., Chignol M.C., Souchier C., Le Griel C., Schmitt D., Serres M. Cell migration and MMP-9 secretion are increased by epidermal growth factor in HaCaT-ras transfected cells. Exp. Dermatol. 1998, 7:184-190.
16. Chen J.K., Capdevila J., Harris R.C. Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol. Cell Biol. 2001, 21:6322-6331.
17. Chua H.L., Bhat-Nakshatri P., Clare S.E., Morimiya A., Badve S., Nakshatri H. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 2007, 26:711-724.
18. Cicchini C., Laudadio I., Citarella F., Corazzari M., Steindler C., Conigliaro A., Fantoni A., Amicone L., Tripodi M. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp. Cell Res. 2008, 314:143-152.
19. Conacci-Sorrell M., Simcha I., Ben-Yedidia T., Blechman J., Savagner P., Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J. Cell Biol. 2003, 163:847-857.
20. Cortes-Reynosa P., Robledo T., Macias-Silva M., Wu S.V., Salazar E.P. Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol. 2008, 27:220-231.
21. Dong R., Wang Q., He X.L., Chu Y.K., Lu J.G., Ma Q.J. Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial-mesenchymal transition of MCF-7 cells. Braz. J. Med. Biol. Res. 2007, 40:1071-1078.
22. Duong T.D., Erickson C.A. MMP-2 plays an essential role in producing epithelial-mesenchymal transformations in the avian embryo. Dev. Dyn. 2004, 229:42-53.
23. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
24. Eger A., Aigner K., Sonderegger S., Dampier B., Oehler S., Schreiber M., Berx G., Cano A., Beug H., Foisner R. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005, 24:2375-2385.
25. Fay M.P., Freedman L.S., Clifford C.K., Midthune D.N. Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res. 1997, 57:3979-3988.
26. Felber J.P., Golay A. Pathways from obesity to diabetes. Int. J. Obes. Relat. Metab. Disord. 2002, 26:S39-45.
27. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003, 3:453-458.
28. Gavert N., Ben-Ze'ev A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol. Med. 2008, 14:199-209.
29. Gavert N., Conacci-Sorrell M., Gast D., Schneider A., Altevogt P., Brabletz T., Ben-Ze'ev A. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J. Cell Biol. 2005, 168:633-642.
30. Geback T., Schulz M.M., Koumoutsakos P., Detmar M. TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 2009, 46:265-274.
31. Gilles C., Polette M., Mestdagt M., Nawrocki-Raby B., Ruggeri P., Birembaut P., Foidart J.M. Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res. 2003, 63:2658-2664.
32. Gilles C., Polette M., Piette J., Delvigne A.C., Thompson E.W., Foidart J.M., Birembaut P. Vimentin expression in cervical carcinomas: association with invasive and migratory potential. J. Pathol. 1996, 180:175-180.
33. Gilles C., Polette M., Zahm J.M., Tournier J.M., Volders L., Foidart J.M., Birembaut P. Vimentin contributes to human mammary epithelial cell migration. J. Cell Sci. 1999, 112:4615-4625.
34. Glaser K.B., Mobilio D., Chang J.Y., Senko N. Phospholipase A2 enzymes: regulation and inhibition. Trends Pharmacol. Sci. 1993, 14:92-98.
35. Gradl D., Kuhl M., Wedlich D. The Wnt/Wg signal transducer beta-catenin controls fibronectin expression. Mol. Cell Biol. 1999, 19:5576-5587.
36. Grunert S., Jechlinger M., Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 2003, 4:657-665.
37. Guaita S., Puig I., Franci C., Garrido M., Dominguez D., Batlle E., Sancho E., Dedhar S., De Herreros A.G., Baulida J. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J. Biol. Chem. 2002, 277:39209-39216.
38. Gumbiner B.M. Regulation of cadherin-mediated adhesion in morphogenesis. Nat. Rev. Mol. Cell Biol. 2005, 6:622-634.
39. Halbleib J.M., Nelson W.J. Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev. 2006, 20:3199-3214.
40. Han Y.P., Tuan T.L., Wu H., Hughes M., Garner W.L. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J. Cell Sci. 2001, 114:131-139.
41. Hardy S., St-Onge G.G., Joly E., Langelier Y., Prentki M. Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J. Biol. Chem. 2005, 280:13285-13291.
42. Hay E.D. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev. Dyn. 2005, 233:706-720.
43. Hazan R.B., Phillips G.R., Qiao R.F., Norton L., Aaronson S.A. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 2000, 148:779-790.
44. Hendrix M.J., Seftor E.A., Chu Y.W., Trevor K.T., Seftor R.E. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev. 1996, 15:507-525.
45. Himelstein B.P., Lee E.J., Sato H., Seiki M., Muschel R.J. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene 1997, 14:1995-1998.
46. Hlubek F., Jung A., Kotzor N., Kirchner T., Brabletz T. Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res. 2001, 61:8089-8093.
47. Hollier B.G., Evans K., Mani S.A. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J. Mammary Gland Biol. Neoplasia 2009, 14:29-43.
48. Huber M.A., Azoitei N., Baumann B., Grunert S., Sommer A., Pehamberger H., Kraut N., Beug H., Wirth T. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 2004, 114:569-581.
49. Huber M.A., Kraut N., Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 2005, 17:548-558.
50. Ikenouchi J., Matsuda M., Furuse M., Tsukita S. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J. Cell Sci. 2003, 116:1959-1967.
51. Irby R.B., Yeatman T.J. Role of Src expression and activation in human cancer. Oncogene 2000, 19:5636-5642.
52. Jarasch E.D., Nagle R.B., Kaufmann M., Maurer C., Bocker W.J. Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum. Pathol. 1988, 19:276-289.
53. Kang Y., Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004, 118:277-279.
54. Karin M., Cao Y., Greten F.R., Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2002, 2:301-310.
55. Karni R., Levitzki A. pp60(cSrc) is a caspase-3 substrate and is essential for the transformed phenotype of A431 cells. Mol. Cell Biol. Res. Commun. 2000, 3:98-104.
56. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997, 275:1784-1787.
57. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 2006, 172:973-981.
58. Lee M.M., Lin S.S. Dietary fat and breast cancer. Annu. Rev. Nutr. 2000, 20:221-248.
59. Lemieux E., Bergeron S., Durand V., Asselin C., Saucier C., Rivard N. Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis. Int. J. Cancer 2009, 125:1575-1586.
60. Leslie C.C. Regulation of arachidonic acid availability for eicosanoid production. Biochem. Cell Biol. 2004, 82:1-17.
61. Lilienbaum A., Paulin D. Activation of the human vimentin gene by the Tax human T-cell leukemia virus. I. Mechanisms of regulation by the NF-kappa B transcription factor. J. Biol. Chem. 1993, 268:2180-2188.
62. Llorens A., Rodrigo I., Lopez-Barcons L., Gonzalez-Garrigues M., Lozano E., Vinyals A., Quintanilla M., Cano A., Fabra A. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. Lab Invest. 1998, 78:1131-1142.
63. Lo C.Y., Hsieh P.H., Chen H.F., Su H.M. A maternal high-fat diet during pregnancy in rats results in a greater risk of carcinogen-induced mammary tumors in the female offspring than exposure to a high-fat diet in postnatal life. Int. J. Cancer 2009, 125:767-773.
64. Lopez-Perez M., Salazar E.P. A role for the cytoskeleton in STAT5 activation in MCF7 human breast cancer cells stimulated with EGF. Int. J. Biochem. Cell Biol. 2006, 38:1716-1728.
65. Malzahn K., Mitze M., Thoenes M., Moll R. Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas. Virchows Arch. 1998, 433:119-129.
66. Mandal M., Myers J.N., Lippman S.M., Johnson F.M., Williams M.D., Rayala S., Ohshiro K., Rosenthal D.I., Weber R.S., Gallick G.E., El-Naggar A.K. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 2008, 112:2088-2100.
67. Mann B., Gelos M., Siedow A., Hanski M.L., Gratchev A., Ilyas M., Bodmer W.F., Moyer M.P., Riecken E.O., Buhr H.J., Hanski C. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. USA 1999, 96:1603-1608.
68. Mayer R.J., Marshall L.A. New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and -nonselective enzymes. Faseb J. 1993, 7:339-348.
69. Mezentsev A., Seta F., Dunn M.W., Ono N., Falck J.R., Laniado-Schwartzman M. Eicosanoid regulation of vascular endothelial growth factor expression and angiogenesis in microvessel endothelial cells. J. Biol. Chem. 2002, 277:18670-18676.
70. Min C., Eddy S.F., Sherr D.H., Sonenshein G.E. NF-kappaB and epithelial to mesenchymal transition of cancer. J. Cell Biochem. 2008, 104:733-744.
71. Moncada S., Higgs E.A. Metabolism of arachidonic acid. Ann. NY Acad. Sci. 1988, 522:454-463.
72. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275:1787-1790.
73. Navarro-Tito N., Robledo T., Salazar E.P. Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells. Exp. Cell Res. 2008, 314:3340-3355.
74. Navarro P., Lozano E., Cano A. Expression of E- or P-cadherin is not sufficient to modify the morphology and the tumorigenic behavior of murine spindle carcinoma cells. Possible involvement of plakoglobin. J. Cell Sci. 1993, 105:923-934.
75. Nielsen B.S., Rank F., Lopez J.M., Balbin M., Vizoso F., Lund L.R., Dano K., Lopez-Otin C. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res. 2001, 61:7091-7100.
76. Nieman M.T., Prudoff R.S., Johnson K.R., Wheelock M.J. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 1999, 147:631-644.
77. Ohkubo T., Ozawa M. The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J. Cell Sci. 2004, 117:1675-1685.
78. Orlowski R.Z., Baldwin A.S. NF-kappaB as a therapeutic target in cancer. Trends Mol. Med. 2002, 8:385-389.
79. Otterbach F., Bankfalvi A., Bergner S., Decker T., Krech R., Boecker W. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 2000, 37:232-240.
80. Owens D.W., McLean G.W., Wyke A.W., Paraskeva C., Parkinson E.K., Frame M.C., Brunton V.G. The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol. Biol. Cell 2000, 11:51-64.
81. Panini S.R., Yang L., Rusinol A.E., Sinensky M.S., Bonventre J.V., Leslie C.C. Arachidonate metabolism and the signaling pathway of induction of apoptosis by oxidized LDL/oxysterol. J. Lipid Res. 2001, 42:1678-1686.
82. Parsons J.T. Focal adhesion kinase: the first ten years. J. Cell Sci. 2003, 116:1409-1416.
83. Parsons J.T., Parsons S.J. Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr. Opin. Cell Biol. 1997, 9:187-192.
84. Peifer M., McCrea P.D., Green K.J., Wieschaus E., Gumbiner B.M. The vertebrate adhesive junction proteins beta-catenin and plakoglobin and the Drosophila segment polarity gene armadillo form a multigene family with similar properties. J. Cell. Biol. 1992, 118:681-691.
85. Peinado H., Portillo F., Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 2004, 48:365-375.
86. Piomelli D. Arachidonic acid in cell signaling. Curr. Opin. Cell Biol. 1993, 5:274-280.
87. Planas-Silva M.D., Waltz P.K. Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells. J. Steroid. Biochem. Mol. Biol. 2007, 104:11-21.
88. Polakis P. Wnt signaling and cancer. Genes Dev. 2000, 14:1837-1851.
89. Ramaekers F.C., Haag D., Kant A., Moesker O., Jap P.H., Vooijs G.P. Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc. Natl. Acad. Sci. USA 1983, 80:2618-2622.
90. Rha S.Y., Yang W.I., Kim J.H., Roh J.K., Min J.S., Lee K.S., Kim B.S., Chung H.C. Different expression patterns of MMP-2 and MMP-9 in breast cancer. Oncol. Rep. 1998, 5:875-879.
91. Robledo T., Arriaga-Pizano L., Lopez-Perez M., Salazar E.P. Type IV collagen induces STAT5 activation in MCF7 human breast cancer cells. Matrix Biol. 2005, 24:469-477.
92. Rose D.P. Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am. J. Clin. Nutr. 1997, 66:1513S-1522S.
93. Sadot E., Simcha I., Shtutman M., Ben-Ze'ev A., Geiger B. Inhibition of beta-catenin-mediated transactivation by cadherin derivatives. Proc. Natl. Acad. Sci. USA 1998, 95:15339-15344.
94. Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001, 23:912-923.
95. Schlaepfer D.D., Mitra S.K. Multiple connections link FAK to cell motility and invasion. Curr. Opin. Genet. Dev. 2004, 14:92-101.
96. Schulz M., Hoffmann K., Weikert C., Nothlings U., Schulze M.B., Boeing H. Identification of a dietary pattern characterized by high-fat food choices associated with increased risk of breast cancer: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Br. J. Nutr. 2008, 100:942-946.
97. Sheng H., Shao J., Washington M.K., DuBois R.N. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 2001, 276:18075-18081.
98. Shtutman M., Levina E., Ohouo P., Baig M., Roninson I.B. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res. 2006, 66:11370-11380.
99. Slack J.K., Adams R.B., Rovin J.D., Bissonette E.A., Stoker C.E., Parsons J.T. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Oncogene 2001, 20:1152-1163.
100. Steinert P.M., Roop D.R. Molecular and cellular biology of intermediate filaments. Annu. Rev. Biochem. 1988, 57:593-625.
101. Takei H., Iino Y., Horiguchi J., Kanoh T., Takao Y., Oyama T., Morishita Y. Immunohistochemical analysis of cytokeratin #8 as a prognostic factor in invasive breast carcinoma. Anticancer Res. 1995, 15:1101-1105.
102. Tang D.G., Chen Y.Q., Honn K.V. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc. Natl. Acad. Sci. USA 1996, 93:5241-5246.
103. Tatosyan A.G., Mizenina O.A. Kinases of the Src family: structure and functions. Biochemistry (Mosc) 2000, 65:49-58.
104. Tepass U., Truong K., Godt D., Ikura M., Peifer M. Cadherins in embryonic and neural morphogenesis. Nat. Rev. Mol. Cell Biol. 2000, 1:91-100.
105. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
106. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 2003, 15:740-746.
107. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7:131-142.
108. Thompson E.W., Newgreen D.F., Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?. Cancer Res. 2005, 65:5991-5995. discussion 5995.
109. Tot T. The cytokeratin profile of medullary carcinoma of the breast. Histopathology 2000, 37:175-181.
110. Tsai C.N., Tsai C.L., Tse K.P., Chang H.Y., Chang Y.S. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc. Natl. Acad. Sci. USA 2002, 99:10084-10089.
111. Uttamsingh S., Bao X., Nguyen K.T., Bhanot M., Gong J., Chan J.L., Liu F., Chu T.T., Wang L.H. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 2008, 27:2626-2634.
112. Wetzels R.H., Kuijpers H.J., Lane E.B., Leigh I.M., Troyanovsky S.M., Holland R., van Haelst U.J., Ramaekers F.C. Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am. J. Pathol. 1991, 138:751-763.
113. Wheelock M.J., Shintani Y., Maeda M., Fukumoto Y., Johnson K.R. Cadherin switching. J. Cell Sci. 2008, 121:727-735.
114. Yonezawa T., Katoh K., Obara Y. Existence of GPR40 functioning in a human breast cancer cell line, MCF-7. Biochem. Biophys. Res. Commun. 2004, 314:805-809.